Angela Drew
Camargo Pharmaceutical Services, USA
Biography
Angela Drew is a Product Ideation Consultant at Camargo Pharmaceutical Services. Angela has an academic background in inflammatory diseases and cancer, and a regulatory background in FDA submissions for approval via the 505(b)(2) regulatory pathway. Angela has industry experience with US and Australian regulatory submissions, and experience with global clinical program oversight. She is experienced in Product Ideation and design of drug development programs.
Abstract
Abstract : Drug approval pathways in the US: A focus on the 505(b)(2) pathway and the role of BA/BE studies